Lázár Laszló, Szakonyi Zsolt, Forró Eniko, Palkó Márta, Zalán Zita, Szatmári István, Fülöp Ferenc
Szegedi Tudományegyetem, Gyógyszerkémiai Intézet, Szeged, Eötvös u. 6. - 6720.
Acta Pharm Hung. 2004;74(1):11-8.
Two-step transformations (N-nitrosation and subsequent LiAlH4 reduction) of alicyclic or acyclic amines and 1,2-amino alcohols containing a secondary amino group were applied to prepare novel N1-substituted hydrazines and hydrazino alcohols with wide structural diversity. Methods for the synthesis of certain enantiopure hydrazino alcohols were also developed. The prepared compounds specifically inhibited Vascular Adhesion Protein-1 (VAP-1), a human endothelial cell adhesion molecule with a well-documented role in inflammation. VAP-1 is a semicarbazide-sensitive amine oxidase, activity of which has been demonstrated to play a role in VAP-1 induced inflammation. Some of the hydrazino alcohols obtained reduced the clinical symptoms of inflammation in experimental arthritis in rodents and appear to be potential novel anti-inflammatory drugs.
采用两步转化法(N-亚硝化及随后的LiAlH₄还原),对含有仲氨基的脂环族或脂肪族胺以及1,2-氨基醇进行转化,以制备具有广泛结构多样性的新型N¹-取代肼和肼醇。还开发了某些对映体纯的肼醇的合成方法。所制备的化合物能特异性抑制血管黏附蛋白-1(VAP-1),这是一种人类内皮细胞黏附分子,在炎症中发挥着重要作用,已有充分文献记载。VAP-1是一种对氨基脲敏感的胺氧化酶,其活性已被证明在VAP-1诱导的炎症中起作用。所获得的一些肼醇减轻了啮齿动物实验性关节炎的炎症临床症状,似乎是潜在的新型抗炎药物。